Ontvang nu dagelijks onze kooptips!

word abonnee
IEX 25 jaar desktop iconMarkt Monitor

Amerikaanse aandelen« Terug naar discussie overzicht

Artificial Life ...enjoy the Iphone hype!

116 Posts
Pagina: «« 1 2 3 4 5 6 | Laatste | Omlaag ↓
  1. [verwijderd] 12 januari 2011 15:21
    Artificial Life and 3M in agreement to develop products

    Jan 11, 2011 (M2 EQUITYBITES via COMTEX) --

    Artificial intelligence and mobile technology company Artificial Life Inc (OTCBB: ALIF.ob) has agreed with diversified technology company 3M Company (NYSE: MMM | PowerRating) to launch three distinct pilot projects to co-develop innovative joint mobile products in 2011.

    3M said on Monday that it has invested approximately USD6.5m in October 2009 to acquire an equity stake of 10% in Artificial Life ( ALIF | PowerRating).

    The companies intend to develop three pilot projects, which reportedly comes after a paid evaluation period of approximately 14 months during which Artificial Life had developed several show case and prototype mobile and augmented reality applications for a number of business units of 3M globally.

    In addition, 3M and Artificial Life have entered into an alliance agreement outlining their intent to collaborate in the coming years on projects related to the research and development of new mobile device products and technology.

    Bron:
    www.tradingmarkets.com/news/stock-ale...
  2. [verwijderd] 13 januari 2011 13:55
    Artificial Life Announces 96% Increase in iPhone/iPod/iPad Downloads

    HONG KONG and LOS ANGELES, Jan. 13, 2011 /PRNewswire-Asia/ -- Artificial Life, Inc., (OTC Bulletin Board: ALIF) (http://www.artificial-life.com), today revealed its current iPhone/iPod and iPad title sales, download numbers and key ranking statistics.

    The total number of iPhone/iPod/iPad application downloads generated for the year of 2010 was over 15.7 million in comparison to 8 million downloads in 2009.

    As of December 31st, 2010, the Company has produced and released 36 applications for the iPhone, iPod touch and iPad. The top title was downloaded for over 6.2 million times, the second most for over 3.4 million times, and the third most for close to 3.1 million times. The average number of downloads per game was about 0.66 million. Paid iPhone games were sold at between USD 0.99 to USD 4.99 with an average price per game of USD 2.27. All the new games released have achieved Top 100 or higher download rankings in their categories. Artificial Life's (ALIF) games have reached #1 on Apple App Store Top Charts in over 74 countries or 83% of all the offered countries.

    The Company has also gained successful results from penetrating the iPad market. For instance, since the launch of Linkin Park 8-Bit Rebellion! iPad Edition in April, 2010, the game has firmly remained in US Top 20 Paid Music Apps in many countries around the world. Other iPad games have also continued to secure their places in the Top 50 charts even months after their releases. GluCoMo™, the first newly launched healthcare iPhone application for monitoring and coaching diabetic patients, has also received positive results with the achievement of being in the US Top 50 Healthcare & Fitness Apps. The highly popular iPhone games: Amateur Surgeon, Red Bull Racing Challenge, and iSink U have also been ported onto the iPad platform with enhanced features and gameplay.

    Among the 36 produced games, 26 are based on licensed and branded intellectual property from a variety of licensors while 10 games are based on Artificial Life's proprietary IP. The games have been sold in a total of 89 countries worldwide. The distribution of game downloads by region is: 44% in North America, 34% in Europe and Africa, 17% in Asia Pacific, 3% in Latin America and 2% in the Middle East. The Top 5 countries in terms of download numbers for our products are: United States, United Kingdom, France, Germany, and Canada (with 40%, 10%, 5%, 5% and 5% of downloads respectively).

    "2010 has been a very successful year for Artificial Life. Our R&D and technology advancement have greatly contributed in delivering outstanding iPhone/iPod/iPad applications. We will continue to invest in R&D and new game and business apps design to provide highest quality games and business applications for the iPhone and iPad in the year 2011," said Eberhard Schoneburg, CEO of Artificial Life, Inc.

    iPod and iPhone are trademarks of Apple Inc., registered in the US and other countries. iPad a trademark of Apple Inc. App Store is a service mark of Apple Inc.

    Bron:
    www.prnewswire.com/news-releases/arti...
  3. [verwijderd] 20 januari 2011 14:22
    Artificial Life Announces Second Healthcare iPhone/iPad App

    NeuroDerMo: Neurodermatitis Monitoring App for Mobile Platforms

    LOS ANGELES and HONG KONG, Jan. 20, 2011 /PRNewswire-Asia/ -- Artificial Life, Inc., (OTC Bulletin Board: ALIF) (http://www.artificial-life.com), a leading provider of award-winning mobile technology and applications, announced today their upcoming mobile telemedicine health solution, NeuroDerMo, the second in a series of mobile healthcare products. The name "NeuroDerMo" is short for Neurodermatitis + Mobile. Neurodermatitis is a serious skin condition that will be monitored and managed by the application through inputs by patients and caregivers.

    Research shows that six percent of the world's population is suffering from some form of neurodermatitis and that its prevalence globally is on the rise*. This skin disorder may be associated with other medical conditions such as psychological disorders, depression anxiety, nervousness eczema and/or psoriasis. It can also be exacerbated by chronic scratching and is common in children*.

    NeuroDerMo is launched as a management solution for this segment of the population suffering from neurodermatitis and can be used as an aid in the successful treatment of the condition. This product leverages Artificial Life 's (ALIF) OPUS-M™ platform for end-consumers, healthcare providers and healthcare businesses. NeuroDerMo is scheduled for commercial availability in early Q2 2011. The product follows the Company's successful launch of their first healthcare monitoring mobile application GluCoMo™, a diabetes monitoring mobile application on the iPhone and iPad.

    Introducing NeuroDerMo

    The NeuroDerMo app is a mobile telemedicine and healthcare solution allowing patients, caregivers, doctors, and hospitals to share and communicate through mobile mediums such as smartphones, tablets, netbooks and other mobile internet devices. The goal is to track changes in skin conditions by closely monitoring many variables (such as redness, itchiness, etc.) which is facilitated by mobile data sharing and smart back-end processes. The NeruoDerMo app will enable remote and real-time monitoring and management of patients by doctors and hospitals with enhanced healthcare services which can result in a reduction in administration costs. NeuroDerMo offers an easily accessible repository of monitoring data for the neurodermatitis condition for patients to share with friends, families and caregivers.

    NeruoDerMo has a customized mobile device front-end client and portal as well as a custom back-end infrastructure supported by Artificial Life's m-commerce solution OPUS-M™:

    Front-end

    The NeuroDerMo front-end is comprised of two parts, a mobile client and a web portal. The mobile client is able to support most major smartphone platforms; allowing users to keep track of relevant information in real time such as wound condition tracking, food and medication intake and more. A photo diary with camera snapshots of affected areas gives users a chronological visual diary of their condition history. Sharing of information is also simplified and promoted through online social communities and forums so that users can quickly share their latest medical status, wound conditions, and other medical information with others. For greater flexibility and convenience, a synchronized web portal is also available for users and their friends, family members, and caregivers.

    Back-end

    The NeuroDerMo back-end is powered by Artificial Life's OPUS-M™ technology and allows for friends, families, and caregivers to share critical information with each other.

    Business Model

    The front-end mobile client of NeuroDerMo will initially be launched as a free mobile app and service with limited features. Depending on the needs of the users, additional premium features and functions for the mobile client can then be purchased inside the mobile app in the coming versions.

    NeuroDerMo will soon also be offered as a white label solution and can be adopted by doctors, health clinics, hospitals and/or healthcare industry businesses. The pricing of the customization, integration and maintenance services are based on monthly rental and usage fees.

    "Artificial Life further expands its telemedicine health app portfolio with our upcoming launch of NeuroDerMo, a powerful mobile monitoring solution for patients suffering from neurodermatitis. We plan to grow more in the telemedicine field and will soon expand our healthcare app portfolio to include a wide-ranging family of mobile monitoring apps available across many smartphone platforms," said Eberhard Schoneburg, CEO of Artificial Life, Inc.

    *Source: Scha¨fer, Gu¨nther N. Psoriasis - Neurodermatitis, Atopic Eczema Answers to Everyday Questions from A - Z. [Bad Sa¨ckingen]: G. N. Scha¨fer, 2006. Print.
    Reitamo, S., Thomas A. Luger, and Martin Steinhoff. Textbook of Atopic Dermatitis. London: Informa Healthcare, 2008. Print.

    *iPhone and iPad are trademarks of Apple Inc., registered in the U.S. and other countries.

    Bron:
    www.prnewswire.com/news-releases/arti...
  4. [verwijderd] 21 januari 2011 14:22
    RELATIVELY HIGH FORWARD EARNINGS YIELD IN THE INTERNET SOFTWARE & SERVICES INDUSTRY DETECTED IN SHARES OF ARTIFICIAL LIFE (ALIF, LOCM, TCTZF, UNTD, AOL)

    Jan 21, 2011 (SmarTrend(R) News Watch via COMTEX) -- Below are the highest five companies in the Internet Software & Services industry based on estimated Forward Earnings Yields. Using projected earnings for the current fiscal year, the forward earnings yield is useful to compare a stock's return vs. owning a similar stock or other yield assets (e.g. bonds). Generally, the higher the earnings yield, the more undervalued the stock.

    Artificial Life (NASDAQ:ALIF) has the highest Forward Earnings Yield of 28.7%; Local.com (NASDAQ:LOCM) is next with a Forward Earnings Yield of 19.9%; and Tencent Holdings (NASDAQ:TCTZF) has the next highest with a Forward Earnings Yield of 17.8%.

    United Online (NASDAQ:UNTD) follows with a Forward Earnings Yield of 15.0% and AOL (NYSE:AOL) rounds out the group with a Forward Earnings Yield of 12.7%.

    SmarTrend currently has shares of United Online in an Uptrend and issued the Uptrend alert on September 27, 2010 at $5.81. The stock has risen 21.2% since the Uptrend alert was issued.

    Bron:
    www.zacks.com/research/get_news.php?i...
  5. [verwijderd] 9 februari 2011 14:55
    Artificial Life's iSink U Game Sets Sail on Android Platform

    HONG KONG and LOS ANGELES, Feb. 9, 2011 /PRNewswire-Asia/ -- Artificial Life, Inc., (OTC Bulletin Board: ALIF), (http://www.artificial-life.com), a leading provider of award-winning mobile technology and applications, announced today the launch of iSink U for free on the Android platform.

    Following the success of the iSink U title on the Apple App Store, the classic naval strategy game is now extended onto the Android platform. In iSink U, the player becomes the sea captain and must command a squadron of powerful ships to obliterate the enemy. Once each captain has had the chance to strategically position his armada, the battle begins! Players take turns and decide whether to move a ship, fire a weapon, or unleash a series of bombs.

    Utilizing the Android platform, iSink U allows for complex 3D camera movements, such as zooming in/out and panning. In addition to the finely-tuned 3D graphics, iSink U has an enjoyable soundtrack with realistic audio effects, which creates a unique battlefield experience and launches the classic naval strategy game onto the next generation of platforms.

    Game Features:

    * Attack system factors decision-making into the battle strategy by introducing attacks based on Action Points
    * Battle in full 3D aquatic environments with maps of Tropical, Frozen Front, War Zone and Bubbly Bay
    * Strategically utilize a fleet of warships such as the Cruiser, Battleship, Submarine, and more
    * Commence sea assault with friends by playing the Head-2-Head mode
    * Unlock a hidden map after claiming victory in all levels
    * Earn prestigious medals to prove superiority as a sea commander

    The game may be accessed through the Android Market at this link market.android.com/details?id=com.ali... which also includes gamer reviews and other app information.

    iSink U is the Company's first title to launch in the hugely popular and rapidly expanding Android Market. Upcoming titles that will follow this launch include GluCoMo™, a diabetes monitoring app, as well as many more titles from the Company's extensive collection of games and applications.

    iSink U is being offered globally for free as the game utilizes the AdMob ad-network to generate revenues with in-app advertising. To see the game video and to download iSink U free of charge, please go to:

    www.botme.com/ref/android/iSinkU

    "Following its popular demand and warm reception on the iPhone and iPad platforms, iSink U is now available to Android users. Artificial Life will continue to expand in the Android market with many more titles lined up to be distributed throughout the year," said Eberhard Schoneburg, CEO of Artificial Life, Inc. (ALIF)
  6. [verwijderd] 6 april 2011 14:39
    Artificial Life Reaches 58 Million Mobile Apps and Games Downloads

    HONG KONG and LOS ANGELES, April 6, 2011 /PRNewswire-Asia/ -- Artificial Life, Inc., (OTC BB: ALIF), today revealed its current title sales, download numbers, and key ranking statistics for smart phone and feature phone apps.
    As of March 31, 2010, Artificial Life (ALIF)'s accumulated number of downloads now exceeds 58 million. This number includes downloads from iPhone/iPod touch and iPad, Android, Windows Phone 7, and Java title sales.
    Artificial Life has produced and released 36 applications for iPhone, iPod touch and iPad. The top title has been downloaded over 7.45 million times, with the second and third most popular titles receiving 3.63 million and 3.61 million downloads each. On average, each game developed by Artificial Life has received over 766,000 downloads.
    Paid iPhone games were sold for between USD 0.99 and USD 4.99 with an average price per game of USD 1.43. All new games released have achieved Top 100 or higher download rankings in their categories.
    Artificial Life's games have reached the #1 spot on the Apple App Store Top Charts in over 74 countries or 83% of all the offered countries and have gained frequent mentions in specialized App Store sections such as "New and Noteworthy" and "What We're Playing".
    The Company continues to gain favorable results from penetrating the ever-growing iPad market. For instance, since the launch of the Linkin Park 8-Bit Rebellion! iPad Edition in April 2010, the game has firmly remained in the US Top 20 of the Paid Music App chart and has placed as a Top 10 paid iPad app in many countries around the world including Australia, Russia, Denmark, Germany and Finland, among others. The Company's iPad games have also remained in the Top 50 overall paid app charts many months after their initial releases. The highly popular iPhone games Amateur Surgeon, Red Bull Racing Challenge, and iSink U have all been ported onto the iPad platform with enhanced features and gameplay. GluCoMo™, Artificial Life's healthcare iPhone application for monitoring and coaching diabetes patients, has been well received by iPad users and is enjoying positive results with the achievement of being in the US Top 50 Healthcare & Fitness Apps.
    Among the 36 produced iPhone titles, 26 are based on licensed and branded intellectual property from a variety of licensors while 10 titles are based on Artificial Life's proprietary IP. The games have been sold in a total of 90 countries worldwide. The distribution of game downloads by region is: 43% in North America, 34% in Europe and Africa, 18% in Asia Pacific, 3% in Latin America and 2% in the Middle East. The Top 5 countries in terms of download numbers are: United States, United Kingdom, France, Germany, and Canada (with 39%, 10%, 5%, 5% and 4% of downloads respectively).
    Currently, Artificial Life offers 18 applications free to play, 2 games with in-app purchase and 3 applications with in-app advertisements.
    "By reaching the nearly 60 million download milestone, 2011 has started off strongly for Artificial Life, and we will build on the momentum generated in Q1. Our creative team has many more ideas and concepts for the remainder of the year and is working diligently to deliver even more high quality, innovative games and apps to our customers," said Eberhard Schoneburg, CEO of Artificial Life, Inc.

    Bron:
    www.prnewswire.com/news-releases/arti...
  7. [verwijderd] 6 april 2011 14:59
    Ik zie net dat dit draadje, sinds 11 oktober 2010 uit niets anders bestaat dan het kopieren en plakken van PR's door ondergetekende. En dat heeft de koers echt niet geholpen.
    Geen reacties, wat hoogstwaarschijnlijk betekent dat ik de enige ben die deze in het oog houd? Misschien beter dat ik stop, in de hoop dat dat de koers helpt?
    En nu zit ik weer tegen mezelf te typen...!?
  8. [verwijderd] 16 april 2011 21:13
    Artificial Life, Inc. (OTC Bulletin Board: ALIF), a leading provider of award-winning mobile technology and applications, announced today an expansion of its business into South Africa through the extension of its Opus-M Health platform to include an application that will be used for the care management of HIV/AIDS patients.
    The Company (ALIF) announced that it is in the process of establishing an office in South Africa in Stellenbosch near Capetown for its South African operations. The new business activities will be carried out in close co-operation with M-Health Middle East Ltd., a recent investment partner with Artificial Life. Both companies will focus on developing and expanding their mobile health care services and products customized for South Africa. The Company is in negotiations with several additional business partners in the region and is in the process of recruiting senior executives to assist in its efforts of building up local operations.

    The Company currently already provides two mobile health monitoring apps: GluCoMo™, a diabetes monitoring app, and Opus-M Health: Neurodermatitis an app for monitoring the skin condition known as neurodermatitis. In the past, these two applications were targeted mainly to industrialized markets. However, GluCoMo™ as well as the upcoming patient monitoring app for HIV/AIDS will now also target the BRICS emerging markets of which South Africa is a new member. Featuring functions such as patient/medication monitoring, reminders, and education/health tips, the application will be built especially with the treatment of HIV/AIDS in mind. The Company will again be leveraging its Opus-M technology to power the backend system to ensure reliability and security of user-sensitive data.

    According to AVERT, an estimated 5.6 million people are living with HIV and AIDS in South Africa in 2009 – more than any other country. It is estimated that in the same year, around 310,000 South Africans died of AIDS. The highest prevalence age group is 15-49, at 17.8 percent.

    According to International Telecommunication Union's survey, South Africa is Africa's biggest mobile phone market as of 2009, with over 46.4 million mobile users. The number is forecasted to pass 52 million at the end of 2015. Also, data from On Device Research shows that 57 percent of South Africa's mobile Web users have never, or infrequently use the desktop Web.

    The application will be offered to provide support and awareness to patients and caregivers as universally as possible. In an effort to further expand its reach, the Company aims to develop the application not only for smartphone platforms such as iOS, Android, and Windows Phone 7, but also for lower grade phones.

    The Company is in discussions with major health care providers and other partners to make the application available to a broader audience for free. The goal is to offer the mobile app for free to the end user and have health care providers, insurances and advertisers cover the cost.

    "We believe that the BRICS markets will be central for mobile health services in the future. South Africa is a vast country with a strong need for diabetes and HIV/AIDS services especially for its non affluent population. We hope we can help with our products to improve the health care situation in South Africa," said Eberhard Schoneburg, CEO of Artificial Life, Inc.

    Bron:
    pr-usa.net/index.php?option=com_conte...
  9. [verwijderd] 22 juli 2011 13:57
    Artificial Life Partners with MXit

    Distributing Games on Africa's Largest Social Network

    HONG KONG and BERLIN, July 22, 2011 /PRNewswire-Asia/ -- Artificial Life, Inc. (OTCPK:ALIF), a leading provider of award-winning mobile technology and applications, today signed a content agreement with MXit Lifestyle to distribute its games on the MXit Platform.

    The agreement entails Artificial Life (ALIF) to sell their games through the MXit social networking and mobile chat platform in the Republic of South Africa and Africa. MXit users are able to purchase games with MXit's virtual currency, Moola.

    "As we are expanding our target marketing in the BRICS region, we are happy to partner with the largest social network in Africa. This opportunity will introduce Artificial Life's games to a broader audience at a much faster pace," said Eberhard Schoneburg, CEO of Artificial Life, Inc.

    Bron:
    www.prnewswire.com/news-releases/arti...
116 Posts
Pagina: «« 1 2 3 4 5 6 | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.